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Following the online publication of this paper, the authors noticed that the control loading panel for total MET levels in the nontreated A549-GFP cells in Figure 5A was incorrectly inserted. The mistake has been amended online and the correct western blot panel has been inserted in the final version of [Figure 5](#fig5){ref-type="fig"}, shown below. The authors apologize for any possible confusion this error might have caused.Figure 5TNS4-MET Interaction Attenuates MET Internalization and Lysosomal Targeting(A) Endocytosis rate of biotinylated cell-surface MET in A549-TNS4_WT-GFP and control A549-GFP cells ± HGF (30 ng/ml) (mean ± SEM band intensity normalized to end point \[20 min\]; n = 3). Statistical differences at each time point between GFP- and TNS4_WT-GFP-overexpressing cells were analyzed by Student's t test.(B) FACS analysis of cell-surface MET endocytosis rate in A549-GFP, A549-TNS4_WT-GFP, or A549-TNS4_R474A-GFP cells ± HGF (30 ng/ml, 30 min) (mean ± SEM fluorescence intensity; n = 3).(C) Total MET levels in control-, TNS4-, and GGA3-silenced A549 cells treated with DMSO or HGF (30 ng/ml, 1 hr) (mean ± SEM band intensity normalized to control-silenced cells; n = 3). Statistical significance was analyzed between control-silenced cells and the other conditions.(D) Endocytosis rate of biotinylated cell-surface β1-integrin was measured as described in (A).(E) MET and active β1-integrin coendocytosis upon HGF induction (30 ng/ml) in A549 cells labeled with cell-surface-bound MET (antibody directed against extracellular domain) and β1-integrin (12G10) antibodies. Scale bar, 10 μm.(F) A549 cells cotransfected with TNS4 \_WT-GFP or TNS4_R474A-GFP mutant and Lamp1-RFP were stained for MET (antibody directed against extracellular domain) after HGF (30 ng/ml) induction. r: Pearson's correlation coefficient between Lamp1-RFP and MET staining in cells (mean ± SEM; n = 7 cells per condition). Scale bar, 10 μm. ^∗^p \< 0.05, ^∗∗^p \< 0.005, ^∗∗∗^p \< 0.0005.
